March 30, 2009 11:20:48 am
Cadila Healthcare said on Monday its Zydus Cadila has signed a collaborative drug discovery and development deal with US-based Eli Lilly to develop drugs for cardiovascular diseases.
Under the deal,Zydus could receive up to $300 million in potential milestone payments and royalties from sales of a drug developed from the collaboration,the Indian firm said in a statement.
📣 Join our Telegram channel (The Indian Express) for the latest news and updates
- The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.